NEJM:转移性透明细胞肉瘤-病例报道

2020-07-23 MedSci原创 MedSci原创

患者为一名62岁的男子,因腹胀、腹泻和体重减轻(8公斤)5个月而就诊。病史中主要有2年前切除局部口腔透明细胞肉瘤,且未经进一步治疗。

患者为一名62岁的男子,因腹胀、腹泻和体重减轻(8公斤)5个月而就诊。病史中主要有2年前切除局部口腔透明细胞肉瘤,且未经进一步治疗。

体格检查显示颈部淋巴结肿大和腹胀。腹部计算机断层扫描发现大量葡萄状结节(如图A所示)。该患者接受了腹部病变的超声引导下活检,组织病理学分析发现为透明细胞肉瘤(如图B所示)。免疫组化分析发现S100蛋白阳性,且对HMB45单克隆抗体具有反应。

透明细胞肉瘤是源自神经嵴细胞的恶性软组织肿瘤,它在形态学、免疫组化和超微结构上与恶性黑色素瘤具有相似性。该癌症通常会影响年轻人的四肢,很少累及口腔和腹腔。辅助治疗的效果尚不确定,治疗通常为手术切除。

经过四个周期的靶向治疗后,患者拒绝进一步治疗,并在就诊后约9个月死亡。

原始出处:

Xing Huang,et al.Metastatic Clear-Cell Sarcoma.N Engl J Med 2020;https://www.nejm.org/doi/full/10.1056/NEJMicm1913435

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2076146, encodeId=eefb20e6146d2, content=<a href='/topic/show?id=b92f94820f2' target=_blank style='color:#2F92EE;'>#透明细胞肉瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94820, encryptionId=b92f94820f2, topicName=透明细胞肉瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Tue Oct 27 23:13:02 CST 2020, time=2020-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886244, encodeId=63f388624475, content=已读, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c305416237, createdName=ms2000001313681173, createdTime=Fri Sep 18 05:14:27 CST 2020, time=2020-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1386646, encodeId=82381386646ab, content=<a href='/topic/show?id=f08293399f9' target=_blank style='color:#2F92EE;'>#转移性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93399, encryptionId=f08293399f9, topicName=转移性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sat Jul 25 04:13:02 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035355, encodeId=441e10353553c, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Jul 23 16:13:02 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804110, encodeId=5bf280411045, content=免疫, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200720/956eb01f4b594ee783debae7a44d9096/e569cb8381764328b493c23491d86c27.jpg, createdBy=2cbc5401622, createdName=老婆子, createdTime=Thu Jul 23 15:03:49 CST 2020, time=2020-07-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2076146, encodeId=eefb20e6146d2, content=<a href='/topic/show?id=b92f94820f2' target=_blank style='color:#2F92EE;'>#透明细胞肉瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94820, encryptionId=b92f94820f2, topicName=透明细胞肉瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Tue Oct 27 23:13:02 CST 2020, time=2020-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886244, encodeId=63f388624475, content=已读, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c305416237, createdName=ms2000001313681173, createdTime=Fri Sep 18 05:14:27 CST 2020, time=2020-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1386646, encodeId=82381386646ab, content=<a href='/topic/show?id=f08293399f9' target=_blank style='color:#2F92EE;'>#转移性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93399, encryptionId=f08293399f9, topicName=转移性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sat Jul 25 04:13:02 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035355, encodeId=441e10353553c, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Jul 23 16:13:02 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804110, encodeId=5bf280411045, content=免疫, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200720/956eb01f4b594ee783debae7a44d9096/e569cb8381764328b493c23491d86c27.jpg, createdBy=2cbc5401622, createdName=老婆子, createdTime=Thu Jul 23 15:03:49 CST 2020, time=2020-07-23, status=1, ipAttribution=)]
    2020-09-18 ms2000001313681173

    已读

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2076146, encodeId=eefb20e6146d2, content=<a href='/topic/show?id=b92f94820f2' target=_blank style='color:#2F92EE;'>#透明细胞肉瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94820, encryptionId=b92f94820f2, topicName=透明细胞肉瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Tue Oct 27 23:13:02 CST 2020, time=2020-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886244, encodeId=63f388624475, content=已读, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c305416237, createdName=ms2000001313681173, createdTime=Fri Sep 18 05:14:27 CST 2020, time=2020-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1386646, encodeId=82381386646ab, content=<a href='/topic/show?id=f08293399f9' target=_blank style='color:#2F92EE;'>#转移性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93399, encryptionId=f08293399f9, topicName=转移性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sat Jul 25 04:13:02 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035355, encodeId=441e10353553c, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Jul 23 16:13:02 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804110, encodeId=5bf280411045, content=免疫, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200720/956eb01f4b594ee783debae7a44d9096/e569cb8381764328b493c23491d86c27.jpg, createdBy=2cbc5401622, createdName=老婆子, createdTime=Thu Jul 23 15:03:49 CST 2020, time=2020-07-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2076146, encodeId=eefb20e6146d2, content=<a href='/topic/show?id=b92f94820f2' target=_blank style='color:#2F92EE;'>#透明细胞肉瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94820, encryptionId=b92f94820f2, topicName=透明细胞肉瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Tue Oct 27 23:13:02 CST 2020, time=2020-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886244, encodeId=63f388624475, content=已读, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c305416237, createdName=ms2000001313681173, createdTime=Fri Sep 18 05:14:27 CST 2020, time=2020-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1386646, encodeId=82381386646ab, content=<a href='/topic/show?id=f08293399f9' target=_blank style='color:#2F92EE;'>#转移性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93399, encryptionId=f08293399f9, topicName=转移性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sat Jul 25 04:13:02 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035355, encodeId=441e10353553c, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Jul 23 16:13:02 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804110, encodeId=5bf280411045, content=免疫, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200720/956eb01f4b594ee783debae7a44d9096/e569cb8381764328b493c23491d86c27.jpg, createdBy=2cbc5401622, createdName=老婆子, createdTime=Thu Jul 23 15:03:49 CST 2020, time=2020-07-23, status=1, ipAttribution=)]
    2020-07-23 旺医

    顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2076146, encodeId=eefb20e6146d2, content=<a href='/topic/show?id=b92f94820f2' target=_blank style='color:#2F92EE;'>#透明细胞肉瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94820, encryptionId=b92f94820f2, topicName=透明细胞肉瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Tue Oct 27 23:13:02 CST 2020, time=2020-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886244, encodeId=63f388624475, content=已读, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c305416237, createdName=ms2000001313681173, createdTime=Fri Sep 18 05:14:27 CST 2020, time=2020-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1386646, encodeId=82381386646ab, content=<a href='/topic/show?id=f08293399f9' target=_blank style='color:#2F92EE;'>#转移性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93399, encryptionId=f08293399f9, topicName=转移性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sat Jul 25 04:13:02 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035355, encodeId=441e10353553c, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Jul 23 16:13:02 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804110, encodeId=5bf280411045, content=免疫, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200720/956eb01f4b594ee783debae7a44d9096/e569cb8381764328b493c23491d86c27.jpg, createdBy=2cbc5401622, createdName=老婆子, createdTime=Thu Jul 23 15:03:49 CST 2020, time=2020-07-23, status=1, ipAttribution=)]
    2020-07-23 老婆子

    免疫

    0

相关资讯

BMC Endocr Disord:转移部位对神经内分泌肿瘤(NEN)患者生存的影响

神经内分泌肿瘤(NENs)根据肿瘤的起源和级别表现出不同的行为。我们假设肿瘤起源和转移部位可能在生存中起到一定的作用。

Cell Death Dis:CD73通过调节RICS/RhoA信号及EMT进程促进胃癌转移

胃癌(GC)是全球范围的主要健康问题。转移性胃癌是一种致死性疾病,其生存率极低。肿瘤微环境(TME)在塑造癌症多样性过程中起着至关重要的作用,而CD73(ecto-5'-核苷酸酶; NT5E)在TME

肝癌椎管内硬脊膜外转移1例

男,43岁,因胸背部持续性刺痛2个月加重10 d,伴双下肢无力、麻木逐渐加重、大小便功能障碍5 d入院。既往肺结核病史20年,乙型病毒性肝炎病史10年。入院前10 d当地县医院肺部CT检查示双肺上叶、右肺下叶陈旧性结核;胸8椎体水平椎管内异常稍高密度影。

Radiology:FDG PET/MRI联合肝细胞特异性对比剂在直肠癌M分期的价值

PET/MRI在评价直肠癌远处转移(M分期)的价值与对比增强CT相比孰优孰劣尚不清楚。

Cell Death Dis:ASPP1缺乏促进结直肠癌侵袭和转移进展

p53凋亡刺激蛋白(ASPP)家族由三个成员(ASPP1,ASPP2和iASPP)组成,三个成员的C末端序列相似,包括锚蛋白重复序列??、SH3结构域及富含脯氨酸的区域。在功能上,ASPP与凋亡调节蛋

Cell Death & Disease:KLF5能够抑制前列腺癌中STAT3活性和肿瘤转移

KLF5在前列腺癌中经常发生缺失或者下调,且最近报道KLF5的丧失在前列腺癌进化侵袭性分支中富集。然而,为什么KLF5丧失与前列腺癌的侵袭性相关仍旧不清楚。